| LLY | Eli Lilly and Co | 15.90% |
| JNJ | Johnson & Johnson | 9.60% |
| ABBV | AbbVie Inc | 6.98% |
| MRK | Merck & Co Inc | 4.98% |
| NOVN.SW | Novartis AG Registered Shares | 4.50% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 4.49% |
| AMGN | Amgen Inc | 4.36% |
| AZN.L | AstraZeneca PLC | 4.30% |
| GILD | Gilead Sciences Inc | 3.67% |
| NOVO-B.CO | Novo Nordisk AS Class B | 3.59% |
The Portfolio Building Block World Pharma and Biotech Index ETF seeks to provide investors with targeted exposure to the global pharmaceutical and biotechnology industries, two of the most dynamic and innovation-driven sectors in healthcare. The fund seeks to replicate the performance of the BITA Global Pharma and Biotech Select Index, which tracks companies in developed markets that derive a significant portion of their revenue from the discovery, development, and commercialization of human therapeutics.
Portfolio Building Block World Pharma and Biotech Index ETF · Issued by Other
No recent news for PBPH. The ingest cron pulls every 15 minutes during market hours.